Psychopharmacology 3e Chapter 18 Recommended Readings

aan het Rot, M., Mathew, S. J., and Charney, D. S. (2009). Neurobiological mechanisms in major depressive disorder. CMAJ, 180, 305–313.

Albrecht, U. (2017). Molecular mechanisms in mood regulation involving the circadian clock. Front. Neurol., 8, Article 30.

Castrén, E., and Rantamäki, T. (2010). The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev. Neurobiol., 70, 289–297.

Connolly, K. R., and Thase, M. E. (2012). Emerging drugs for major depressive disorder. Expert Opin. Emerg. Drugs, 17, 105–126.

Duman, C. H., and Duman, R. S. (2015). Spine synapse remodeling in the pathophysiology and treatment of depression. Neurosci. Lett., 601, 20–29.

Jamison, K. R. (1993). Touched with Fire: Manic-Depressive Illness and the Artistic Temperament. New York: Free Press/Macmillan.

Logan, R. W., and McClung, C. A. (2016). Animal models of bipolar mania: The past, present and future. Neuroscience, 321, 163–188.

Machado-Vieira, R., Manji, H. K., and Zarate, C. A., Jr. (2009). The role of lithium in the treatment of bipolar disorder: Convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord., 11 (Suppl. 2), 92–109.

McEwen, B. S., and Gianaros, P. J. (2010). Central role of the brain in stress and adaptation: Links to socioeconomic status, health, and disease. Ann. N. Y. Acad. Sci., 1186, 190–222.

Southwick, S. M., Vythilingam, M., and Charney, D. S. (2005). The psychobiology of depression and resilience to stress: Implications for prevention and treatment. Annu. Rev. Clin. Psychol., 1, 255–291.